Blueberry Consumption Improves Vascular Function and Lowers Blood Pressure in Postmenopausal Women With Pre- and Stage 1-hypertension
Daily Incorporation of Blueberries Into a Diet Favorably Improves Vascular Function and Lowers Aortic Blood Pressure in Postmenopausal Women With Pre- and Stage 1-hypertension.
1 other identifier
interventional
48
1 country
1
Brief Summary
Cardiovascular disease (CVD) continues to be the leading cause of death in the U.S. Americans have been more concerned about their blood cholesterol levels and dietary cholesterol intakes rather than their overall cardiovascular health risk factors leading to CVD such as hypertension, vascular dysfunction, inadequate consumption of fruits and vegetables and physical activity. Statistics show that approximately 91% of individuals with CVD have vascular dysfunction which is attributed to endothelial and autonomic dysfunction leading to increased arterial stiffness. The investigators long-term goal is to provide feasible and effective dietary ways for pre- and stage 1- hypertensive individuals to normalize their blood pressure (BP), improve vascular function and thereby reducing their cardiovascular risk and enhancing the quality of life. Blueberries are a rich source of phenolic compounds and these compounds may play an important role in promoting cardiovascular health. Considering the strong possibility that phytochemicals present in blueberry work additively or synergistically, it would be ideal to investigate the cardioprotective effects of blueberry as a whole. The investigators overall objective to bring forth evidence that blueberry consumption will reduce BP and cardiovascular risk factors including endothelial dysfunction, arterial stiffness, and autonomic dysfunction in pre- and stage 1-hypertensive postmenopausal women. The investigators hypothesize that blueberry supplementation will improve vascular function and will lower blood pressure in postmenopausal women with pre-hypertension. The findings of this study will provide a foundation for disseminating feasible, safe approaches for preventing and combating hypertension at its early stage which does not require drug therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jan 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 11, 2012
CompletedFirst Posted
Study publicly available on registry
September 18, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedJanuary 14, 2015
January 1, 2015
1.2 years
September 11, 2012
January 12, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood Pressure
By measuring aortic blood pressure at rest and during physiological stress (handgrip exercise and post-exercise muscle ischemia).
8 weeks
Secondary Outcomes (6)
Autonomic Control of Blood Pressure
8 weeks
Autonomic Control of Heart Rate
8 weeks
Endothelial Function
8 week
Inflammation
8 weeks
Oxidative Stress
8 weeks
- +1 more secondary outcomes
Study Arms (2)
Placebo
PLACEBO COMPARATOR8 weeks of freeze-dried blueberry powder taken in two doses of 22g each per day.
Blueberry
EXPERIMENTAL8 weeks of freeze-dried blueberry powder taken in two doses of 22g each per day.
Interventions
8 weeks of freeze-dried taken in two doses of 22g each per day.
Eligibility Criteria
You may qualify if:
- women (1 to 10 years after natural menopause or bilateral oophorectomy) 45-65 years of age.
- Seated blood pressure ≥ 130/85 mm Hg but ≤ 160/90 mm Hg.
You may not qualify if:
- Blood pressure \>160/100 mmHg
- Taking insulin
- Cardiovascular disease
- Active cancer
- Asthma
- Glaucoma
- Thyroid disease
- Kidney disease
- Liver disease
- Pancreatic disease
- Enrollment in a weight loss program
- Heavy smokers (\>20 cigarettes per day)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Florida State Universitylead
- U.S. Highbush Blueberry Councilcollaborator
Study Sites (1)
The Department of Nutrition, Food, and Exercise Sciences, Florida State University
Tallahassee, Florida, 32306, United States
Related Publications (1)
Johnson SA, Figueroa A, Navaei N, Wong A, Kalfon R, Ormsbee LT, Feresin RG, Elam ML, Hooshmand S, Payton ME, Arjmandi BH. Daily blueberry consumption improves blood pressure and arterial stiffness in postmenopausal women with pre- and stage 1-hypertension: a randomized, double-blind, placebo-controlled clinical trial. J Acad Nutr Diet. 2015 Mar;115(3):369-377. doi: 10.1016/j.jand.2014.11.001. Epub 2015 Jan 8.
PMID: 25578927DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bahram H Arjmandi, PhD, RD
Florida State University
- PRINCIPAL INVESTIGATOR
Arturo Figueroa, MD, PhD
Florida State University
- PRINCIPAL INVESTIGATOR
Sarah A Johnson, PhD, RD, CSO
Florida State University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Margaret A. Sitton Professor and Director of the Center for Advancing Exercise and Nutrition Research on Aging
Study Record Dates
First Submitted
September 11, 2012
First Posted
September 18, 2012
Study Start
January 1, 2012
Primary Completion
March 1, 2013
Study Completion
January 1, 2014
Last Updated
January 14, 2015
Record last verified: 2015-01